Diarrhea Associated Costs among Children Less Than 5 Years of Age from Health Care Provider and Social Perspectives in Albania
Keywords:Albania, Diarrhea, Health Care Costs, Primary Care, Social Costs.
Background: Diarrheal diseases count for a considerable proportion of morbidity, mortality and elevated use of health services and costs, especially in developing countries. In limited resource countries like Albania, it is essential to assess the costs associated with diarrhea, from health provider and social perspective, as a first step toward prioritization of interventions.
Materials and Methods: We used the 2011 information by gathering data from primary care, emergency rooms (ER) and hospitals. Average non-medical and medical costs were used. To assess the social costs of diarrhea we interviewed parents of children with diarrhea. Based on this information the total cost of diarrhea in Albania was calculated.
Results: The total mean cost per hospitalized, emergency room and outpatient diarrhea case was $228.97, $17.68 and $9.24, respectively. The total social costs per each hospitalized, ER and outpatient diarrhea case were $45.66, $15.22 and $15.22, respectively. The final burden of diarrhea, in terms of costs, in Albania was approximately $3 million in 2011.Conclusion: The high burden of diarrhea associated costs for the Albanian health care system finances dictates the necessity to assess the costs of a potential rotavirus immunization program in order to prioritize the interventions based on scientific evidence.
Kosek M, Bern C, Guerrant RL. The Global Burden Of Diarrhoeal Disease, As Estimated From Studies Published Between 1992 And 2000. Bull World Health Organ. 2003; 81(3):197-204.
De Zoysa I, Feachem RG. Interventions For The Control Of Diarrheal Disease Among Young Children: Rotavirus And Cholera Immunization. Bull World Health Organ. 1985; 63:569â€“83.
Jin S, Kilgore PE, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI. Trends In Hospitalizations For Diarrhea In United States Children From 1979 Through 1992: Estimates Of The Morbidity Associated With Rotavirus. Pediatr Infect Dis J. 1996; 15(5):397-404.
Granados-GarcÃa V, VelÃ¡zquez-Castillo R, GarduÃ±o-Espinosa J, Torres-LÃ³pez J, MuÃ±oz-HernÃ¡ndez O. Resource Utilization And Costs Of Treating Severe Rotavirus Diarrhea In Young Mexican Children From The Health Care Provider Perspective. Rev Invest Clin. 2009; 61(1):18-25.
Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global Illness And Deaths Caused By Rotavirus Disease In Children. Emerg Infect Dis. 2003; 9(5):565-72.
Zimmerman CM, Bresee JS, Parashar UD, Riggs TL, Holman RC, Glass RI. Cost Of Diarrhea-Associated Hospitalizations And Outpatient Visits In An Insured Population Of Young Children In The United States. Pediatr Infect Dis J. 2001; 20(1):14-9.
Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho Le H, Glass RI, Bresee JS. Health Care Costs Of Diarrheal Disease And Estimates Of The Cost-Effectiveness Of Rotavirus Vaccination In Vietnam. J Infect Dis. 2005; 192(10):1720-6.
Alvis-Guzman N, Orozco-Africano J, Paternina-Caicedo A, Coronell-RodrÃguez W, Alvis-Estrada L, Jervis-JÃ¡labe D, De La Hoz-Restrepo F. Treatment Costs Of Diarrheal Disease And All-Cause Pneumonia Among Children Under-5 Years Of Age In Colombia. Vaccine. 2013; 31( Suppl 3):C58-62.
Department Of Economy, Ministry Of Health, Tirana, Albania 2011 [In Albanian].
Decision of the Council of Ministers Nr. 748, DatÃ« 2.11.2011 â€œPÃ«r NjÃ« Ndryshim NÃ« Vendimin Nr. 69, DatÃ« 02.02.2011 TÃ« KÃ«shillit TÃ« Ministrave â€œPÃ«r Miratimin E Kuadrit Makroekonomik E Fiskal PÃ«r PeriudhÃ«n 2012-2014â€, TÃ« Ndryshuar. [In Albanian].
Institute Of Statistics, Tirana, Albania.
Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-Effectiveness Analysis of a Rotavirus Immunization Program for the United States. JAMA. 1998; 279:1371â€“6.
Isakbaeva ET, Musabaev E, Antil L, Rheingans R, Juraev R, Glass RI, Bresee JS. Rotavirus Disease In Uzbekistan: Cost-Effectiveness Of A New Vaccine. Vaccine. 2007; 25(2):373-80.
Carlin JB, Jackson T, Lane L, Bishop RF, Barnes GL. Cost Effectiveness Of Rotavirus Vaccination In Australia. Austr N Z J Public Health. 1999; 23:611â€“6.
Podewils LJ, Antil L, Hummelman E, Bresee JS, Parashar UD, Rheingans R. Projected Cost-Effectiveness Of Rotavirus Vaccination For Children In Asia. J Infect Dis. 2005; 192(Suppl 1):S133-45.
Soriano-GabarrÃ³ M, Mrukowicz J, Vesikari T, Verstraeten T.) Burden Of Rotavirus Disease In European Union Countries. Pediatr Infect Dis J. 2006; 25(1 Suppl):S7-S11.
How to Cite
All rights reserved.